Results 101 to 110 of about 22,164 (138)

Reversal of Left Bundle Branch Block Following Treatment in Alcoholic Cardiomyopathy. [PDF]

Arq Bras Cardiol
Barroso MCRD, Madogolele HDCN, Belfort DSP, Biselli B, Ayub-Ferreira SM, Bocchi EA.   +5 more
europepmc   +1 more source

Novel biomarkers for CKD risk stratification: a literature review. [PDF]

J Bras Nefrol
Khan S, Zobairi A, Rehan E, Mohammed AH.
europepmc   +1 more source

Constrictive Pericarditis with Caseous Necrosis: A Rare and Underrecognized Presentation. [PDF]

Arq Bras Cardiol
Wolf PJW, Correia EB, Vasconcellos MO, Bruscky LVR, Murta ACS, Francisco YA, Sassaki EM, Domingos SRA, Donadon NA, Miranda G, Rossi R, Mattos VBM, Fortuna FB.   +12 more
europepmc   +1 more source

[Comment on the article "Retinal ischemia as an early marker of renal failure in non-proliferative retinopathy"]. [PDF]

Rev Med Inst Mex Seguro Soc
Grajales-Garcia DP.
europepmc   +1 more source

Apical Sparing and Granular Sparkling: Not Everything that Glitters Is Cardiac Amyloidosis. [PDF]

Arq Bras Cardiol
Barros APM, Romero CE, Cardoso JN, Fernandes F, Hotta VT.   +4 more
europepmc   +1 more source

Improvement in kidney function in patients with chronic hepatitis B and chronic kidney disease after switching to tenofovir alafenamide fumarate: a systematic review with single arm meta-analysis. [PDF]

J Bras Nefrol
Pascoa Junior JG, Huntermann R, Gomes VMV, Mendes Filho FSM, Bertozzi JMV, Lins PRG.   +5 more
europepmc   +1 more source

Long-term mortality and predictive score performance in Brazilian atherosclerotic renovascular disease patients. [PDF]

J Bras Nefrol
Salome JG, Moraes LP, Hagemann R, Silva VDS, Carvalho FC, Franco RJDS, Vassallo D, Martin LC, Kalra PA, Barretti P.   +9 more
europepmc   +1 more source

Clinical Outcomes and Mortality in Patients with Implantable Cardioverter-Defibrillator for Primary Prevention. [PDF]

Arq Bras Cardiol
Başkurt AA, Güneri S, Yılancıoğlu RY, Turan OE, Özcan EE.   +4 more
europepmc   +1 more source

[Incidence, associated comorbidity, and risk factors for severe exacerbation of chronic obstructive pulmonary disease: A retrospective cohort study 2021-2022]. [PDF]

Aten Primaria
Montserrat-Capdevila J, Vaqué Castilla P, Gea-Sánchez M, Olivares-Sanzo P.   +3 more
europepmc   +1 more source

Papel del laboratorio clínico en el estudio de nefrolitiasis y cristaluria por mesalazina. [PDF]

Adv Lab Med
Balbuena AI, Poveda N, López A, Ferri MJ.   +3 more
europepmc   +1 more source